Abbott

Abbott (NYSE:ABT)  is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.

Abbott (NYSE:ABT) raised price target to $122 from $114 by Barclays

/ / Health Care / ,

Barclays Bank analyst Matt Miksic released a research report saying that maintaining a positive interest in Abbott  (NYSE:ABT) with an increased price target of $122 from $114. Miksic noted that while the macro backdrop remains challenging for the medical supplies and equipment industry, and the timing of inflationary pressures, supply chain issues and hospital staffing challenges is not yet clear, Miksic remains optimistic about the industry overall, believing that future product sales trends in the industry will improve, industry staffing is gradually stabilizing, and supply chain and inflation cost issues will also stabilize. Miksic said it will continue to be bullish on Abbott’s stable operating leverage and tailwind prospects for the company’s future. It said the company will have the ability to attract market capital and operate to achieve higher market valuations.

Abbott (NYSE:ABT) raised price target to $122 from $114 by Barclays Read Post »

Abbott (NYSE:ABT)Stock price trend forecast and trading range -2023.1.6

/ / Health Care /

Abbott (NYSE:ABT) Stock price trend forecast and trading range: Updated to: 2023.1.6 (Note: The upper red line in the picture is the resistance, and the lower red line is the support) Analysis from stock chart —————————————————————- Short-term trend: up Sell high and buy low of range : above 20-day moving average Support: 20-day moving average resistance: $112 Stop Loss Price: 20-day moving average price target: $112 Buy the position again: stop fall and rise to 20-day moving average Medium-term trend: rebound High sell low buy range: above 20-day moving average Support: 20-day moving average resistance: $117 Stop Loss price: 20-day moving average price target: $117 Buy the position again: stop fall and rise to 20-day moving average Long-term trend: rebound High sell low buy of range: above 30-day moving average Support : 30-day moving average resistance: $123 Stop Loss price: 20-day moving average price target : $123 Buy the position

Abbott (NYSE:ABT)Stock price trend forecast and trading range -2023.1.6 Read Post »

Abbott (NYSE:ABT) Stock Price Trend Forecast and Market Analysis-2022.12.30

/ / Health Care /

Abbott (NYSE:ABT) stock price trend forecast and market analysis: 2022.12.30 From the stock chart analysis, the recent stock price rebounded 18% from the previous low point following the main index. The current stock price is more likely to choose the direction of fluctuation, mainly depending on the performance of the index. I think there is a high probability that the stock price will fall to the 60-day EMA again, continuing to test the lower support level downward. Short-term trades above $105, a target price of $112, and a stop loss price of $105. From Analysis from financial statements, Q3 2022 achieved operating income of US$10.41 billion, YoY-4.74%, net profit attributable to common shareholders of US$1.435 billion, YoY-31.67%, and EPS of US$0.81. Quarterly dividend of $0.47 per share. The sales growth rate has turned negative in Q3, the net profit has fallen significantly, and there is a large downside in the

Abbott (NYSE:ABT) Stock Price Trend Forecast and Market Analysis-2022.12.30 Read Post »

Scroll to Top